
P1 Bringing the TMF In-house: Is It Time to Bring Your TMF In-House?
No se pudo agregar al carrito
Solo puedes tener X títulos en el carrito para realizar el pago.
Add to Cart failed.
Por favor prueba de nuevo más tarde
Error al Agregar a Lista de Deseos.
Por favor prueba de nuevo más tarde
Error al eliminar de la lista de deseos.
Por favor prueba de nuevo más tarde
Error al añadir a tu biblioteca
Por favor intenta de nuevo
Error al seguir el podcast
Intenta nuevamente
Error al dejar de seguir el podcast
Intenta nuevamente
-
Narrado por:
-
De:
Acerca de esta escucha
Join Agatha Head of North American Operations, Ken Lownie, and Janine Penman, JPScientific, as they take you through the strategy of bringing your TMF in-house.
In part one of the series, Ken and Janine discuss the following:
- Who typically "owns" the TMF?
- Is there a pattern between larger and smaller sponsors as to when the TMF is usually outsourced?
- What is the "best practice" for smaller, clinical-stage sponsors regarding TMF management
- What is driving the need to bring the TMF in-house and how do you know WHEN it makes sense for a specific organization to think about taking the TMF in-house?
- The challenges involved when moving from your CRO managing the TMF to bringing it in-house.
Sign up for Agatha's newsletter to get updated when each new episode in the series goes live and to get additional insights on each episode.
Todavía no hay opiniones